In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

36th Annual JPM Healthcare Conference
- gtmrick
- December 25, 2017
- Uncategorized
You Might Also Like

Vasomune Announces FDA Allowance of IND Application for AV-001 for the Treatment of Hospitalized Patients with COVID-19

Preventing the flu: Researchers looking for a new approach
